FMO5 and Cognitive impairment: Notably, treatment with APO, an NADPH oxidase inhibitor, abolished the enhanced oxidative stress and neuroinflammation and subsequently prevented the dysfunction of PV interneurons in the hippocampus, which ultimately improved postoperative cognitive impairment in mice.